Results 81 to 90 of about 1,161 (101)

Research progress in estrogen as an adjunctive therapy for schizophrenia. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Ge Y, Zhang S, Ge X, Li R, Zhai J, Gao Y.   +5 more
europepmc   +1 more source

[Role of m6A methylation modification in photoaging and ultraviolet-induced skin cancers]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Hou Y, Zhang X, Liu J, Wu J.
europepmc   +1 more source

[Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Pan SA, Shi J.
europepmc   +1 more source

[Research progress in liver cancer in 2025]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Miao TG, Nan YM.
europepmc   +1 more source

[Research Progress on Quorum Sensing-Regulated Oral Microbial Interaction Networks in Periodontitis]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Li L, Yu Z, Xu Y.
europepmc   +1 more source

[A pan-cancer analysis of PYCR1 and its predictive value for chemotherapy and immunotherapy responses in bladder cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li Y, Song X, Sun R, Dong X, Liu H.
europepmc   +1 more source

[Guardians of Immune Tolerance: Regulatory T Cells]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Ming K, Zhang H, Hu H.
europepmc   +1 more source

[Distribution and Drug Resistance Characteristics of Pathogenic Bacteria in the Elderly Population in China in 2021]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Tang S, Xiao Y, Li J, Li D, Wu S, Huang X, Li J, Yang L, Li J, Wang T, Zhang G, Xu Y, Xie Y.   +12 more
europepmc   +1 more source

[Efficacy and safety of venetoclax combined with tyrosine kinase inhibitors and reduced-dose chemotherapy in 13 cases of minimal residual disease-positive and relapsed/refractory Ph(+) acute lymphoblastic leukemia]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Ai H, Liang TT, Wang Q, Wu HF, Yin QS.
europepmc   +1 more source